From June 2 to 5, HIPRA Peru took part in the Latin American Veterinary Conference (LAVC), one of the most important continuing education events in veterinary medicine in Peru and Latin America. More than 2,500 companion animals veterinarians attended lectures and the commercial exhibition. 

Over the course of the three-day event, the HIPRA Peru team, along with the regional team, engaged with more than 250 veterinarians, presenting the advantages and benefits of the HIPRADOG® vaccine range, which has contributed to increasing our market penetration in Peru. 

This participation is part of the company’s strategy to strengthen its position in the companion animal sector, where it currently ranks third in the Peruvian biologicals market for pet disease prevention. 

With its fourth consecutive participation at LAVC 2025 and the positive outcomes achieved in each edition, HIPRA reaffirms its leadership in the veterinary sector and its ongoing commitment to innovation and positioning—delivering top-quality animal health solutions, including companion animals.